Patent Term Extension Application for CRENESSITY™ (crinecerfont), Patent No. 11,730,739 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-0508

Patent Term Extension Application for CRENESSITY™ (crinecerfont), Patent No. 11,730,739

Documents

Comments

Description

Open

Comment Period OpensFeb 28, 2025

Comment Period ClosesApr 15, 2026

Type	Title	Posted	Comments	Status
Notice	Determination of Regulatory Review Period for Purposes of Patent Extension; CRENESSITY FR Doc: 2026-02973	Feb 13, 2026	--

CDER

Patent Term Extension Application

Patent No. 11,730,739

CRENESSITY™ (crinecerfont)

Neurocrine Biosciences, Inc.

Finnegan, Henderson, Farabow,

Garrett & Dunner, L.L.P.

Open